| pubmed-article:542191 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:542191 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
| pubmed-article:542191 | lifeskim:mentions | umls-concept:C0010711 | lld:lifeskim |
| pubmed-article:542191 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:542191 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:542191 | lifeskim:mentions | umls-concept:C0035052 | lld:lifeskim |
| pubmed-article:542191 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:542191 | lifeskim:mentions | umls-concept:C1710063 | lld:lifeskim |
| pubmed-article:542191 | lifeskim:mentions | umls-concept:C0085752 | lld:lifeskim |
| pubmed-article:542191 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:542191 | pubmed:dateCreated | 1980-6-16 | lld:pubmed |
| pubmed-article:542191 | pubmed:abstractText | Forty-six previously untreated patients with acute nonlymphocytic leukemia were treated with a remission induction regimen consisting of three daily doses of Adriamycin (30 mg/m2/day) and a ten-day continuous infusion of cytosine arabinoside (ara C) (100 mg/m2/day). The overall remission rate was 72%, with 88% of the patients less than 50 and 62% of patients greater than 50 years old achieving complete remission status. Thirty-one of the 33 complete remissions occurred after a single course of chemotherapy. Retrospective comparison of this regimen with its predecessor (identical, except that a seven-day infusion of ara C was administered) demonstrated that the increase in duration of ara C administration resulted in greater antileukemic effectiveness without an increase in hematologic toxicity to the patient. | lld:pubmed |
| pubmed-article:542191 | pubmed:language | eng | lld:pubmed |
| pubmed-article:542191 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:542191 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:542191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:542191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:542191 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:542191 | pubmed:issn | 0098-1532 | lld:pubmed |
| pubmed-article:542191 | pubmed:author | pubmed-author:HendersonE... | lld:pubmed |
| pubmed-article:542191 | pubmed:author | pubmed-author:NaeherCC | lld:pubmed |
| pubmed-article:542191 | pubmed:author | pubmed-author:BjornssonSS | lld:pubmed |
| pubmed-article:542191 | pubmed:author | pubmed-author:HryniukWW | lld:pubmed |
| pubmed-article:542191 | pubmed:author | pubmed-author:FreemanAA | lld:pubmed |
| pubmed-article:542191 | pubmed:author | pubmed-author:PreislerHH | lld:pubmed |
| pubmed-article:542191 | pubmed:author | pubmed-author:HigbyDD | lld:pubmed |
| pubmed-article:542191 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:542191 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:542191 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:542191 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:542191 | pubmed:pagination | 269-75 | lld:pubmed |
| pubmed-article:542191 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-H... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-A... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-A... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-L... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-C... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-C... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-F... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-M... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-A... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-M... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-T... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-D... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-C... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-R... | lld:pubmed |
| pubmed-article:542191 | pubmed:meshHeading | pubmed-meshheading:542191-D... | lld:pubmed |
| pubmed-article:542191 | pubmed:year | 1979 | lld:pubmed |
| pubmed-article:542191 | pubmed:articleTitle | Remission induction in acute nonlymphocytic leukemia: comparison of a seven-day and ten-day infusion of cytosine arabinoside in combination with adriamycin. | lld:pubmed |
| pubmed-article:542191 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:542191 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:542191 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
